With Beneflora®, Biolab advances in the probiotics market
With an eye on the dynamic probiotics market, Biolab presents Beneflora®Beneflora is a product indicated for the maintenance of gastrointestinal flora in adults. Each dose of Beneflora® contains five billion CFUs that act directly to re-establish the intestinal flora, helping to relieve common symptoms such as diarrhea, colds and other discomforts.
The product uses the Lactobacillus acidophilus NCFM strain, from the Premium Line of International Flavors & Fragrances, a world reference brand in probiotics.
With a focus on practicality, Beneflora® has no taste and its formulation is versatile, it can be consumed with or without dilution, as well as being non-prescription and found in packs of six sachets of 4g each.
About Biolab
Promoting a future with a better quality of life requires a tireless search for safe and innovative treatments. That's why Biolab, a Brazilian pharmaceutical company founded in 1997 and with an international presence, invests in research and partnerships to overcome the growing challenges of health.
With almost 4,000 employees and the 4th largest sales force in the country, the company stands out among Brazil's largest pharmaceutical companies. In 2025, it was recognized by LinkedIn Top Companies as one of the 15 best places to work in Brazil, based on criteria such as growth opportunities, skills development, diversity and stability.
Biolab operates in various specialties, such as dermatology, gynecology, orthopedics, gastroenterology, pediatrics, clinical medicine and the central nervous system, as well as being a leader in cardiology. The Biolab Genéricos, Avert Humana and Avert Biolab Saúde Animal business units contribute to a portfolio of more than 500 products.
Biolab is constantly growing. It has three production units, as well as a modern manufacturing complex under construction. And it doesn't stop there: in Canada, it is the first Brazilian pharmaceutical company with a research center and has acquired the company Exzell Pharma to expand its borders. Long live evolution!